Clinical trials
Recruiting Phase 2 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,123 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 7 |
| 2013 | 5 |
| 2014 | 10 |
| 2015 | 17 |
| 2016 | 15 |
| 2017 | 23 |
| 2018 | 40 |
| 2019 | 57 |
| 2020 | 95 |
| 2021 | 155 |
| 2022 | 213 |
| 2023 | 331 |
| 2024 | 539 |
| 2025 | 827 |
| 2026 | 765 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3,123 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 155 |
| Memorial Sloan Kettering Cancer Center | 106 |
| National Cancer Institute (NCI) | 99 |
| Mayo Clinic | 62 |
| Massachusetts General Hospital | 45 |
| Yale University | 45 |
| City of Hope Medical Center | 43 |
| Emory University | 39 |
| Washington University School of Medicine | 33 |
| Stanford University | 31 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 138 |
| Prostatic Neoplasms | 115 |
| Carcinoma, Non-Small-Cell Lung | 101 |
| Neoplasms | 69 |
| Multiple Myeloma | 67 |
| Leukemia, Myeloid, Acute | 65 |
| Lung Neoplasms | 64 |
| Colorectal Neoplasms | 51 |
| Squamous Cell Carcinoma of Head and Neck | 51 |
| Neoplasm Metastasis | 49 |
Trials
Showing 1 to 25 of 3,123. Each trial links to its page on Pharma Observatory.
3,023 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.